What Is the Drug Classification of Vistaril (Hydroxyzine)?

Vistaril (hydroxyzine pamoate) is classified as a first-generation antihistamine, specifically an H1 receptor antagonist, but its pharmacological profile extends well beyond allergy relief. The drug carries FDA-approved indications for anxiety, pruritus, and sedation, placing it in an unusual position where it straddles the line between antihistamine and anxiolytic without fitting neatly into either category alone. That dual identity is part of what makes Vistaril’s classification confusing for patients and, sometimes, for the prescribers writing the scripts.

Why Vistaril Straddles Multiple Drug Classes

At its core, hydroxyzine is an antihistamine. It blocks histamine at H1 receptors, which is the same basic mechanism behind familiar over-the-counter allergy drugs. But hydroxyzine also has significant anticholinergic activity and crosses the blood-brain barrier readily, producing sedation and calming effects that newer antihistamines like cetirizine and loratadine were specifically designed to avoid. This central nervous system penetration is exactly what gives Vistaril its usefulness as an anxiolytic, a sedative, and an antiemetic all rolled into one molecule.

In practice, this means you might see Vistaril listed differently depending on who is doing the listing. A pharmacy reference will categorize it as an antihistamine. A psychiatrist’s formulary might file it under anxiolytics. An anesthesiologist’s pre-op protocol may list it as a sedative or antiemetic. A dermatologist reaching for it to help a patient with severe itching is using it for yet another reason. All of these uses trace back to the same pharmacological properties, but they land the drug in different conceptual buckets depending on the clinical context.

Not a Controlled Substance

One of the most practically important aspects of Vistaril’s classification is what it is not: it is not a controlled substance under the DEA’s scheduling system. Unlike benzodiazepines such as lorazepam and alprazolam, which are Schedule IV controlled substances due to their potential for dependence, hydroxyzine carries no schedule designation at all. You do need a prescription for it, but your doctor can prescribe refills without the added regulatory hurdles that come with controlled medications.

This distinction matters for several reasons. Patients who need ongoing anxiety management but have a history of substance use disorders are often steered away from benzodiazepines because of their well-documented abuse potential. Hydroxyzine offers an alternative that acts on anxiety without engaging the same reward pathways. Controlled clinical trials have shown that hydroxyzine does not produce rebound anxiety or withdrawal symptoms after abrupt discontinuation, which sets it apart from the benzodiazepine class in a clinically meaningful way.¹ Limited evidence on non-benzodiazepine anxiolytics as a group suggests they carry a reduced potential for addiction compared to benzodiazepines, though data remain sparse.²

Anxiety Treatment and How the Evidence Stacks Up

Vistaril’s use for anxiety is backed by multiple controlled trials, most of them focused on generalized anxiety disorder. In a three-month double-blind study, patients taking hydroxyzine showed significantly greater improvement on standard anxiety rating scales compared to placebo, with benefits extending to overall clinical severity and measures of both anxiety and depression.³ A separate four-week trial found that hydroxyzine at 50 mg per day produced a meaningful anxiolytic effect starting within the first week, and that improvement held throughout the study and even persisted after the drug was abruptly stopped.⁴

Head-to-head data against benzodiazepines exist as well. In a trial comparing hydroxyzine to lorazepam, hydroxyzine showed greater and more rapid improvement on cognitive aspects of anxiety, which includes symptoms like worry, apprehension, and difficulty concentrating.⁵ That finding runs counter to the common assumption that “real” anxiolytics must be benzodiazepines and that everything else is a weaker substitute. For generalized anxiety specifically, hydroxyzine performs respectably well.

That said, hydroxyzine is generally not considered a first-line treatment for anxiety disorders by most current guidelines. SSRIs and SNRIs tend to occupy that role. Hydroxyzine is more often used as an adjunct, for short-term or situational anxiety, or when other options are contraindicated. Its sedating quality can be a benefit or a drawback depending on the situation.

Vistaril vs. Atarax and the Salt Form Difference

Patients frequently encounter two brand names for hydroxyzine: Vistaril and Atarax. The active molecule is identical in both. The difference is the salt form. Vistaril is hydroxyzine pamoate, while Atarax is hydroxyzine hydrochloride (HCl). Once either version reaches your bloodstream, the hydroxyzine molecule behaves the same way. The salt dissolves away and has no pharmacological effect of its own.

In practice, however, the two formulations have historically been marketed for slightly different purposes. Vistaril (pamoate) was promoted primarily for anxiety and sedation and is available as capsules and an oral suspension. Atarax (HCl) was marketed more heavily for itching and allergic conditions, available as tablets and a syrup. These marketing distinctions have become somewhat blurred with time, and generic hydroxyzine HCl is widely prescribed for anxiety today. The point is that there is no meaningful pharmacological difference between the two. If your prescription says hydroxyzine pamoate or hydroxyzine HCl, you are getting the same drug in a different wrapper.

Use for Itching and Skin Conditions

Hydroxyzine’s original and still prominent role is controlling itch. H1 antihistamines are commonly used across dermatology for itch and hives management.⁶ For chronic idiopathic urticaria (persistent hives without a clear cause), hydroxyzine has been shown to reduce the number and size of lesions and the severity of itching compared to placebo over four-week treatment periods.⁷

It is worth noting that cetirizine, the popular over-the-counter antihistamine sold as Zyrtec, is actually a metabolite of hydroxyzine. Your liver converts hydroxyzine into cetirizine as part of normal drug metabolism.⁸ In efficacy studies for urticaria, cetirizine given once daily was found to be equivalent to hydroxyzine given in divided doses throughout the day.⁹ The key difference is that cetirizine does not cross the blood-brain barrier nearly as readily, so it causes far less drowsiness. For pure allergy or itch control, cetirizine is often the more practical choice. But when the sedating effect is actually desirable, say for a patient whose itching is worst at night and disrupts sleep, hydroxyzine’s ability to make you drowsy becomes a feature rather than a bug.

How Hydroxyzine Moves Through the Body

After you swallow a dose of Vistaril, hydroxyzine is absorbed and reaches peak blood levels in roughly two hours. Its elimination half-life averages about 20 hours, meaning that a single dose continues working for a substantial part of the day.¹⁰ That relatively long half-life is reflected in the drug’s antihistamine effect: studies measuring skin wheal suppression (a proxy for how well the drug is blocking histamine) show that the response persists well beyond what you might expect from the initial blood concentration peak.

As the liver processes hydroxyzine, a significant fraction is converted to cetirizine. Animal pharmacokinetic studies have shown that this conversion is rapid and that circulating levels of cetirizine can far exceed those of the parent hydroxyzine compound after a single oral dose.¹¹ This means that some of the antihistamine activity you experience from hydroxyzine is actually being delivered by cetirizine as a downstream product. The sedation, however, comes from the parent compound’s action in the brain, not from cetirizine.

Sedation and Perioperative Use

Hydroxyzine has a long history as a pre-surgical sedative and antiemetic. Before a procedure, controlling anxiety, providing mild sedation, and preventing nausea are all useful goals, and hydroxyzine checks all three boxes with a single drug. A retrospective cohort study found that patients who received hydroxyzine before surgery had significantly lower rates of postoperative nausea and vomiting: roughly 35% experienced nausea on the day of surgery compared to 57% in a group that did not receive it.¹² The benefit persisted through the second postoperative day. While randomized trials are still needed to confirm this, the antiemetic properties of hydroxyzine are well recognized in clinical practice.

In pediatric dentistry specifically, hydroxyzine is used as an oral sedative to reduce anxiety and help children tolerate procedures. Reviews of this use have found that the main adverse effects are drowsiness and dry mouth, and that when dosed appropriately and not combined with other sedating drugs irresponsibly, it does not produce serious adverse events.¹³ The respiratory complications that have been reported in the literature were tied to synergistic interactions when hydroxyzine was combined with other central nervous system depressants, not to hydroxyzine alone.

Side Effects and the QT Prolongation Question

The most common side effects of hydroxyzine are predictable given its mechanism: drowsiness, dry mouth, and dizziness. The drowsiness can be significant, especially at higher doses, and it tends to be most pronounced when you first start the drug. Over time, some people develop partial tolerance to the sedation while still getting the antihistamine and anxiolytic benefits, though this is not universal.

The anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision) are dose-dependent and tend to be mild to moderate at typical doses. In older adults, anticholinergic medications as a class raise concerns about confusion and fall risk, so hydroxyzine is used more cautiously in that population.

A more serious but rare concern emerged in the 2010s when European regulators flagged hydroxyzine for a potential risk of QT interval prolongation, a heart rhythm abnormality that in extreme cases can lead to dangerous arrhythmias. A detailed review of post-marketing safety data found that reports of QT prolongation or its most dangerous form, torsade de pointes, were extremely uncommon. Between 2007 and 2016, across an estimated nearly nine million patient-years of exposure, there were 34 reported cases, translating to a rate of about four cases per million patient-years.¹⁴ This is vanishingly rare, but it prompted some regulatory agencies to recommend dose limits, particularly in elderly patients and those already taking other QT-prolonging medications. If you have a pre-existing heart condition or are on multiple medications, your doctor may want to keep hydroxyzine doses conservative or choose a different drug altogether.

Hydroxyzine in Children

Hydroxyzine is one of the more commonly prescribed medications for young children with itchy skin conditions. A large population-based study of over 24,000 hydroxyzine users under age five found that the overwhelming majority, about 83%, received their prescriptions for dermatological diagnoses. Nearly 70% of those conditions were specifically associated with itch as the main symptom, such as atopic dermatitis and contact dermatitis.¹⁵ The drug’s ability to reduce itching and promote sleep in children trapped in an itch-scratch cycle is its primary pediatric role.

Parents sometimes worry about giving an antihistamine with sedative properties to young children. The pediatric safety data are generally reassuring for appropriate short-term use. The same population study that examined prescribing patterns also looked at neurodevelopmental outcomes, providing a larger evidence base than most older drugs have. As with adults, the main caution is around combining hydroxyzine with other sedating medications, where the risk of excessive sedation and respiratory depression increases.

How Vistaril Compares to Other Common Antihistamines

Understanding where hydroxyzine fits among antihistamines helps clarify why its classification feels ambiguous. Antihistamines are broadly divided into first-generation and second-generation drugs. First-generation antihistamines like hydroxyzine, diphenhydramine, and chlorpheniramine all cross into the brain and cause sedation. Second-generation drugs like cetirizine, loratadine, and fexofenadine were engineered to stay out of the brain, so they control allergies without making you sleepy.

Hydroxyzine occupies a peculiar position even within the first-generation group. While diphenhydramine is available over the counter and widely used as a sleep aid, hydroxyzine remains prescription-only. Part of the reason is its anxiolytic indication: the FDA has approved it specifically for the management of anxiety, a claim that diphenhydramine does not carry. Hydroxyzine also has a longer half-life, meaning its effects last longer per dose. And the connection to cetirizine is unique to hydroxyzine: no other first-generation antihistamine is the direct metabolic precursor to a major second-generation drug.

For patients using hydroxyzine primarily for itching or hives, the conversation with a doctor often comes down to whether the sedation is acceptable. If you need to stay alert during the day, a second-generation antihistamine is generally the better choice. If you are dealing with nighttime itching that disrupts sleep, or if you also have anxiety that could benefit from treatment, hydroxyzine may offer advantages that a non-sedating antihistamine cannot.

Common Misconceptions About Vistaril

Because hydroxyzine is prescribed for anxiety, some patients assume it works like a benzodiazepine, acting fast and producing a noticeable calming sensation within minutes. In reality, hydroxyzine takes one to two hours to reach full effect, and the subjective experience is less of a “calm wash” and more of a gradual reduction in tension and restlessness. People expecting a benzodiazepine-like experience sometimes conclude that Vistaril “doesn’t work,” when in fact it is working through a fundamentally different pathway.

Another misconception is that because Vistaril is not a controlled substance, it is a weak or ineffective medication. As the trial data show, hydroxyzine produces statistically and clinically meaningful improvements in anxiety compared to placebo, and in at least one trial it outperformed lorazepam on cognitive anxiety measures.¹⁶ Non-controlled status is not a commentary on effectiveness. It reflects the drug’s low potential for abuse and dependence.

A third persistent myth is that hydroxyzine is safe to combine freely with alcohol or other sedating substances because it is “just an antihistamine.” Hydroxyzine’s sedative effects are additive with alcohol, opioids, benzodiazepines, and other central nervous system depressants. The combination can lead to excessive sedation, impaired coordination, and in serious cases respiratory depression. The fact that it is unscheduled should not be confused with the idea that it is risk-free when mixed with other substances.

Weight Gain, Long-Term Use, and Tolerance

Patients prescribed Vistaril for ongoing anxiety management often ask whether it causes weight gain. Hydroxyzine does have mild appetite-stimulating effects through its antihistamine activity, since H1 receptors play a role in appetite regulation. However, clinically significant weight gain is not commonly reported in the trial literature, and hydroxyzine is not in the same category as medications like mirtazapine or olanzapine where weight gain is a frequent and well-documented concern.

Tolerance to the sedative effects of hydroxyzine does develop in many people over days to weeks of regular use. Tolerance to the anxiolytic and antihistamine effects appears to be less pronounced, which is why the drug can remain useful for anxiety and itch control even after the initial drowsiness wears off. Unlike benzodiazepines, where tolerance to the anxiolytic effect can drive dose escalation and eventual dependence, hydroxyzine does not appear to produce that pattern. The four-week trial data showing maintained efficacy through the full study period without dose increases, and no rebound after stopping, supports this.¹⁷

For truly long-term use spanning months or years, there is less controlled data. Most of the anxiety trials lasted four weeks to three months. The three-month trial is the longest well-controlled dataset, and it showed sustained benefit without evidence of tolerance to the anti-anxiety effect over that period.¹⁸ Beyond that window, prescribers are extrapolating from clinical experience more than from randomized data, which is true of many psychiatric medications but still worth knowing.